David M Reese Amgen Inc (AMGN) insider trading activity

David M Reese is EVP & Chief Technology Officer of AMGEN INC. Currently has a direct ownership of 61,889 shares of AMGN, which is worth approximately $16.3 Million. The most recent transaction as insider was on May 07, 2024, when has been sold 3,196 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.9K

0% 3M change

14.26% 12M change

Total Value Held $16.3 Million

DAVID M REESE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 07 2024	BUY Grant, award, or other acquisition	-	3,196 Added 4.91%	61,889 Common Stock
May 05 2024	SELL Payment of exercise price or tax liability	$197,046 $311.29 p/Share	633 Reduced 1.07%	58,693 Common Stock
May 02 2024	SELL Payment of exercise price or tax liability	$180,290 $277.37 p/Share	650 Reduced 1.08%	59,326 Common Stock
Apr 30 2024	SELL Payment of exercise price or tax liability	$190,702 $276.38 p/Share	690 Reduced 1.14%	59,976 Common Stock
Mar 18 2024	SELL Payment of exercise price or tax liability	$1,667,531 $268.87 p/Share	6,202 Reduced 9.27%	60,666 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	-	12,407 Added 15.69%	66,653 Common Stock
Nov 28 2023	SELL Bona fide gift	-	165 Reduced 0.3%	54,164 Common Stock
May 05 2023	SELL Payment of exercise price or tax liability	$137,742 $231.89 p/Share	594 Reduced 1.09%	54,114 Common Stock
May 03 2023	SELL Payment of exercise price or tax liability	$193,259 $235.97 p/Share	819 Reduced 1.47%	54,708 Common Stock
May 02 2023	BUY Grant, award, or other acquisition	-	3,814 Added 6.43%	55,527 Common Stock
Apr 30 2023	SELL Payment of exercise price or tax liability	$159,666 $239.74 p/Share	666 Reduced 1.27%	51,713 Common Stock
Mar 17 2023	SELL Payment of exercise price or tax liability	$933,119 $234.57 p/Share	3,978 Reduced 7.06%	52,379 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	7,947 Added 12.4%	56,167 Common Stock
Nov 02 2022	SELL Payment of exercise price or tax liability	$663,826 $272.06 p/Share	2,440 Reduced 4.82%	48,136 Common Stock
May 05 2022	SELL Payment of exercise price or tax liability	$135,758 $236.1 p/Share	575 Reduced 1.13%	50,307 Common Stock
May 03 2022	SELL Payment of exercise price or tax liability	$177,808 $230.92 p/Share	770 Reduced 1.49%	50,882 Common Stock
May 02 2022	BUY Grant, award, or other acquisition	-	3,897 Added 7.02%	51,652 Common Stock
Apr 27 2022	SELL Payment of exercise price or tax liability	$45,976 $249.87 p/Share	184 Reduced 0.38%	47,755 Common Stock
Mar 18 2022	SELL Payment of exercise price or tax liability	$1,178,121 $235.86 p/Share	4,995 Reduced 9.44%	47,939 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	9,989 Added 15.93%	52,714 Common Stock
Nov 02 2021	SELL Payment of exercise price or tax liability	$459,750 $209.74 p/Share	2,192 Reduced 4.89%	42,593 Common Stock
May 03 2021	SELL Payment of exercise price or tax liability	$178,532 $239.64 p/Share	745 Reduced 1.65%	44,472 Common Stock
May 01 2021	SELL Payment of exercise price or tax liability	$265,761 $239.64 p/Share	1,109 Reduced 2.39%	45,217 Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	-	4,006 Added 7.96%	46,326 Common Stock
Apr 27 2021	SELL Payment of exercise price or tax liability	$44,460 $255.52 p/Share	174 Reduced 0.41%	42,320 Common Stock

DMR

David M Reese

EVP & Chief Technology Officer

Thousand Oaks,

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Value

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMGEN INC

Track Activities on AMGN

Account